NO983617L - Vaksine mot Varicella Zoster virusgen 63 produkt - Google Patents

Vaksine mot Varicella Zoster virusgen 63 produkt

Info

Publication number
NO983617L
NO983617L NO983617A NO983617A NO983617L NO 983617 L NO983617 L NO 983617L NO 983617 A NO983617 A NO 983617A NO 983617 A NO983617 A NO 983617A NO 983617 L NO983617 L NO 983617L
Authority
NO
Norway
Prior art keywords
product
vaccine against
zoster virus
virus gene
varicella zoster
Prior art date
Application number
NO983617A
Other languages
English (en)
Other versions
NO983617D0 (no
Inventor
Bernard Rentier
Catherine Sadzot
Original Assignee
Smithkline Beecham Biolog
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602617.4A external-priority patent/GB9602617D0/en
Priority claimed from GBGB9626882.6A external-priority patent/GB9626882D0/en
Application filed by Smithkline Beecham Biolog, Univ Liege filed Critical Smithkline Beecham Biolog
Publication of NO983617D0 publication Critical patent/NO983617D0/no
Publication of NO983617L publication Critical patent/NO983617L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
NO983617A 1996-02-09 1998-08-06 Vaksine mot Varicella Zoster virusgen 63 produkt NO983617L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9602617.4A GB9602617D0 (en) 1996-02-09 1996-02-09 Vaccines
GBGB9626882.6A GB9626882D0 (en) 1996-12-24 1996-12-24 Vaccines
PCT/EP1997/000520 WO1997028820A1 (en) 1996-02-09 1997-02-04 Vaccines against varicella zoster virus gene 63 product

Publications (2)

Publication Number Publication Date
NO983617D0 NO983617D0 (no) 1998-08-06
NO983617L true NO983617L (no) 1998-10-02

Family

ID=26308641

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983617A NO983617L (no) 1996-02-09 1998-08-06 Vaksine mot Varicella Zoster virusgen 63 produkt

Country Status (20)

Country Link
EP (1) EP0879060B1 (no)
JP (1) JP2002504080A (no)
KR (1) KR100365986B1 (no)
CN (1) CN1210470A (no)
AR (1) AR005750A1 (no)
AT (1) ATE390146T1 (no)
AU (1) AU723555B2 (no)
BR (1) BR9707400A (no)
CA (1) CA2245545C (no)
CZ (1) CZ289971B6 (no)
DE (1) DE69738597T2 (no)
ES (1) ES2301175T3 (no)
HU (1) HUP0001991A3 (no)
IL (1) IL125440A (no)
NO (1) NO983617L (no)
NZ (1) NZ331164A (no)
PL (1) PL188457B1 (no)
TR (1) TR199801531T2 (no)
TW (1) TW575427B (no)
WO (1) WO1997028820A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011241A1 (en) * 1997-09-05 1999-03-11 Smithkline Beecham Biologicals S.A. Oil in water emulsions containing saponins
ES2273482T3 (es) * 1998-03-09 2007-05-01 Glaxosmithkline Biologicals S.A. Composiciones de vacunas combinadas.
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
EP1227840B1 (en) * 1999-11-03 2007-10-03 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
CA2400842C (en) 2000-02-23 2013-01-15 Smithkline Beecham Biologicals S.A. Novel compounds
EA020617B1 (ru) 2009-05-27 2014-12-30 Глаксосмитклайн Байолоджикалс С.А. Конструкции casb7439
KR101723605B1 (ko) * 2014-10-21 2017-04-07 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
CN114891830B (zh) * 2022-04-02 2024-03-01 武汉博沃生物科技有限公司 基于水痘-带状疱疹病毒的重组表达载体、重组病毒及用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
ATE119939T1 (de) * 1989-06-27 1995-04-15 Smithkline Beecham Biolog Verbindungen.

Also Published As

Publication number Publication date
CA2245545C (en) 2008-12-30
KR19990082360A (ko) 1999-11-25
TW575427B (en) 2004-02-11
DE69738597T2 (de) 2008-07-24
IL125440A (en) 2002-02-10
CN1210470A (zh) 1999-03-10
DE69738597D1 (de) 2008-05-08
ATE390146T1 (de) 2008-04-15
CA2245545A1 (en) 1997-08-14
NO983617D0 (no) 1998-08-06
WO1997028820A1 (en) 1997-08-14
NZ331164A (en) 2000-02-28
EP0879060B1 (en) 2008-03-26
PL188457B1 (pl) 2005-02-28
TR199801531T2 (xx) 1998-10-21
CZ289971B6 (cs) 2002-05-15
PL328414A1 (en) 1999-01-18
HUP0001991A2 (hu) 2000-10-28
BR9707400A (pt) 2000-01-04
AR005750A1 (es) 1999-07-14
ES2301175T3 (es) 2008-06-16
AU723555B2 (en) 2000-08-31
EP0879060A1 (en) 1998-11-25
JP2002504080A (ja) 2002-02-05
CZ248698A3 (cs) 1998-12-16
HUP0001991A3 (en) 2003-08-28
IL125440A0 (en) 1999-03-12
KR100365986B1 (ko) 2003-02-20
AU1601297A (en) 1997-08-28

Similar Documents

Publication Publication Date Title
ZA945414B (en) DNA virus ribozymes
NO976060D0 (no) Vaksiner mot hepatitt C
DE59608685D1 (de) Stapler
DE69300550D1 (de) Motorisch angetriebenes Klammergerät.
DK0810877T3 (da) Hepatitis B-vaccine
DE69405605D1 (de) Motorisch angetriebenes Klammergerät
DE69426294D1 (de) Rehydrierbares produkt
NO983617L (no) Vaksine mot Varicella Zoster virusgen 63 produkt
DE69606124T2 (de) Abfallblasgerät
IS4629A (is) Samskeyttar veirukjarnsýrur
FR11C0050I2 (fr) Virus myxomateux recombinant
ATE240392T1 (de) Spezifische oligonukleotide fuer hepatitis c- virus
ITMI932517A0 (it) Cassa di soffiante
DE29503459U1 (de) Bodenbelagware
ES1027324Y (es) Soplador
AU7336296A (en) Human hepatitis b virus dna
KR950702244A (ko) 백신으로서의 즉석 초기 hsv-2 비루스 단백질 icp27(immediatie early hsv-2 viral protein icp27 as vaccine)
DE9306009U1 (de) Wärmeboden
DE29507709U1 (de) Saug-/Blasgerät
KR970021240U (ko) 진공발포기
DE69402721D1 (de) Markraumnagelsystem
NO933907D0 (no) Syklonsystem
KR960034942U (ko) 송풍기 유니트
GB9517348D0 (en) Nucleic acids amplification assay
KR970041837U (ko) 송풍기 분해장치